Abstract
Importance
Screening and vaccination are essential in the fight against infectious diseases, but need to be integrated and customized based on community and disease characteristics.
Objective
To develop effective screening and vaccination strategies, customized for a college campus, to reduce COVID-19 infections, hospitalizations, deaths, and peak hospitalizations.
Design, setting, and participants
We construct a compartmental model of disease spread under vaccination and routine screening, and study the efficacy of four mitigation strategies (routine screening only, vaccination only, vaccination with partial or full routine screening), and a no-intervention strategy. The study setting is a hypothetical college campus of 5,000 students and 455 faculty members during the Fall 2021 academic semester, when the Delta variant was the predominant strain. For sensitivity analysis, we vary the screening frequency, daily vaccination rate, initial vaccine coverage, and screening and vaccination compliance; and consider scenarios that represent low/medium/high transmission and test efficacy. Model parameters come from publicly available or published sources.
Results
With low initial vaccine coverage (30% in our study), even aggressive vaccination and screening result in a high number of infections: 1,020 to 2,040 (1,530 to 2,480) with routine daily (every other day) screening of the unvaccinated; 280 to 900 with daily screening extended to the newly vaccinated in base- and worst-case scenarios, which respectively consider reproduction numbers of 4.75 and 6.75 for the Delta variant.
Conclusion
Integrated vaccination and routine screening can allow for a safe opening of a college when both the vaccine effectiveness and the initial vaccine coverage are sufficiently high. The interventions need to be customized considering the initial vaccine coverage, estimated compliance, screening and vaccination capacity, disease transmission and adverse outcome rates, and the number of infections/peak hospitalizations the college is willing to tolerate.
Publisher
Public Library of Science (PLoS)
Reference66 articles.
1. CIDRAP News. China releases genetic data on new coronavirus, now deadly; Accessed on July 2021.
2. QUARTS. Here are the coronavirus testing materials that are in short supply in the U.S.; Accessed on July 2021.
3. The New Yorker. Why widespread coronavirus testing isn’t coming anytime soon; Accessed on July 2021.
4. FDA. FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine; Accessed on July 2021.
5. Assessment of SARS-CoV-2 screening strategies to permit the safe reopening of college campuses in the United States;AD Paltiel;JAMA Network Open,2020
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献